“…3-amino-1-hydroxypropylidene-1,1-diphosphonate (APD) [6,7] and etidronate, 1-hydroxyethylene-diphosphonate (HEDP) [8]. Novel radiopharmaceuticals for the palliation of bone pain have been proposed, which comprises of radiolabelled tin, namely [ 117m Sn]Sn(II) or [ 117m Sn]Sn(IV) [9][10][11]. 117m Sn decays by the emission of conversion electrons and a photon (159 keV, 86.4%), with a half life of 13.6 days.…”